Shield Therapeutics reports positive results in paediatric trial
1st Oct 2025 13:31
(Alliance News) - Shield Therapeutics PLC on Wednesday noted positive efficacy and tolerance results from in its phase three ferric maltol Fortis trial. Read More
| Price | 8.60p on 06-10-2025 at 16:30:08 |
|---|---|
| Change | 0.75p 9.55% |
| Buy | 8.70p |
| Sell | 8.50p |
| Last Trade: | Unknown 125,000.00 at 8.60p |
| Day's Volume: | 5,495,771 |
| Last Close: | 8.60p |
| Open: | 7.85p |
| ISIN: | GB00BYV81293 |
| Day's Range | 8.25p - 8.75p |
| 52wk Range: | 2.20p - 9.00p |
| Market Capitalisation: | £91.32m |
| VWAP: | 8.509275p |
| Shares in Issue: | 1.06b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Shield Thera (STX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 125,000 | 8.60p | OTC Trade |
17:08:08 - 06-Oct-25 |
| Sell* | 100,000 | 8.50p | Ordinary |
16:19:04 - 06-Oct-25 |
| Buy* | 36,000 | 8.65p | Ordinary |
16:18:15 - 06-Oct-25 |
| Sell* | 25,000 | 8.52p | Ordinary |
16:18:08 - 06-Oct-25 |
| Sell* | 100 | 8.50p | SI Trade |
16:17:35 - 06-Oct-25 |
| Sell* | 10,000 | 8.50p | SI Trade |
16:17:35 - 06-Oct-25 |
| Buy* | 100 | 9.00p | SI Trade |
16:17:35 - 06-Oct-25 |
| Buy* | 555 | 9.00p | SI Trade |
16:17:35 - 06-Oct-25 |
| Buy* | 277 | 9.00p | SI Trade |
16:17:35 - 06-Oct-25 |
| Sell* | 250,000 | 8.525p | Ordinary |
16:17:27 - 06-Oct-25 |
Shield Thera (STX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 1st Oct 2025 8:00 am | RNS | Total Voting Rights |
| 1st Oct 2025 7:02 am | RNS | Positive efficacy and tolerance in pediatric trial |
| 15th Sep 2025 7:00 am | RNS | £1.5 million placing supporting growth of ACCRUFeR |
| 4th Sep 2025 7:03 am | RNS | ACCRUFeR® assigned Priority Review in US by FDA |
| 3rd Sep 2025 2:17 pm | RNS | Interim results for the six months ended 30 Jun 25 |
| 27th Aug 2025 7:13 am | RNS | Data published -European Journal of Heart Failure |
| 21st Aug 2025 12:06 pm | RNS | Interim results for the six months ended 30 Jun 25 |
| 23rd Jul 2025 7:00 am | RNS | Q2 2025 Trading Update |
| 22nd May 2025 5:06 pm | RNS | Result of AGM |
| 24th Apr 2025 7:06 am | RNS | Audited results for the year ended 31 Dec 2024 |